companiesSEC EDGAR
Taysha Gene Therapies, Inc.
SEC EDGAR published this disclosure on 2026-08-11. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-344610
cik1806310
company nameTaysha Gene Therapies, Inc.
form10-Q